SPDR Dow Jones Industrial Average ETF

SPDR S&P 500 ETF Trust

Invesco QQQ Trust Series 1

Critical Metals Corp. engages in the mining, exploration, and development of lithium metals. It owns Wolfsberg Project and Tanbreez Project. The company was founded on October 24, 2022 and is headquartered in British Virgin Islands.

Critical Metals Corp.

Critical Metals Corp. is trending amid escalating global tensions, which are intensifying the "critical metals arms race" and underscoring the strategic value of its heavy rare earth deposits for Western defense and technology supply chains. The community is actively discussing an upcoming Bankable Feasibility Study update and potential significant undervaluation revealed by alleged errors in past economic assessments, alongside a key partner's recent Department of War deal.

Derive is a decentralized protocol that creates programmable onchain options, perpetuals, and structured products.   Derive is deployed and operates on Derive Chain, an Ethereum rollup built using the OP stack and is the home of the Derive Protocol. It is a permission-less smart contract platform.  The Derive DAO earns trading fees from the Derive Protocol and gas fees from the Derive Chain, governed by DRV token holders. Trading fees accrue to an insurance fund to foster robustness of the protocol and rollup.  Derive has built an AI-powered trading app built for pro traders. In collaboration with Messari, Derive Pro translates market views into trades. The agent then prepares transactions for users and leverages smart contract wallets to make trades one-click, gasless and chainless. The app will support spot, perps and options trading on Derive, and will also plug in to spot AMMs on L2s like Optimism, Arbitrum and Base.

Derive

DRV is generating significant community attention following its collaboration with Synthetix to build derivatives on ETH L1. Traders are also actively discussing potential token buybacks and observing strong technicals that indicate a potential for continued upward movement.

America's Oil Reserve for the Digital Age

U.S Oil

USOR CRYPTO is trending as a highly speculative memecoin, drawing immense community discussion around a potential "Feb 1st announcement" related to U.S. oil and real-world asset tokenization. Many view it as a pump-and-dump, yet others are playing its volatile swings for quick profits, riding the narrative despite widespread scam warnings.

SSgA Active Trust - State Street Energy Select Sector SPDR ETF

Energy Select Sector SPDR Fund

The Energy Select Sector SPDR Fund (XLE) is in focus as escalating Middle East tensions, including disruptions at the Strait of Hormuz, attacks on key oil infrastructure, and production cuts in Gulf states, are driving a significant "physical squeeze" in global oil supply. The community is actively discussing whether the market is fully pricing in the risk of sustained lost barrels, pushing crude prices higher and potentially impacting the broader economy.

United States Oil Fund LP - United States Oil Fund

United States Oil Fund

United States Oil Fund is trending as escalating Middle East tensions and reports of strikes on Iranian oil infrastructure, coupled with shipping disruptions in the Strait of Hormuz, fuel community speculation of oil prices surging well above $100 due to a tightening supply.

Automatic Data Processing, Inc. engages in the provision of business outsourcing solutions in cloud-based human capital management. It operates through the following business segments: Employer Services, Professional Employer Organization Services, and Other. The Employer Services segment provides clients from single-employee small businesses to large enterprises offering human resources outsourcing and technology-based human capital management solutions and cloud-based platforms. The Professional Employer Organization Services segment offers small and mid-sized businesses a human resource outsourcing solution through a co-employment mode. The Other segment includes the certain corporate overhead charges and expenses that have not been allocated to the reportable segments. The company was founded by Henry Taub in 1949 and is headquartered in Roseland, NJ.

Automatic Data Processing Inc.

Automatic Data Processing is trending as its closely watched employment reports provide critical early insights into the U.S. labor market, heavily influencing Federal Reserve rate cut expectations. The community is also discussing ADP's robust business performance, consistent dividend growth, and the evolving impact of AI on the HR technology sector.

Dogelon Mars

Dogelon Mars is trending as its community grapples with persistent underperformance, recent exchange delistings, and unfulfilled "great burn" promises, leading many to label it a "shitcoin" despite ongoing efforts to generate interest through "Mars land" metaverse integrations. Investors are debating its long-term viability, contrasting its struggles with the performance of other meme coins in the broader market.

Grayscale Bitcoin Mini Trust ETF - Common units of fractional undivided beneficial interest

Grayscale Bitcoin Mini Trust ETF

Bitcoin is experiencing intense volatility, swinging from significant dips to rapid rebounds amid speculation about large exchange selling and geopolitical tensions. The community is sharply divided, with bulls seeing a prime accumulation opportunity in oversold conditions, while bears warn of further declines and question its fundamental role as an asset.

Tidal Trust II - YieldMax NVDA Option Income Strategy ETF

YieldMax NVDA Option Income Strategy ETF

NVDY is actively discussed as investors navigate upcoming dividend payouts and NVIDIA's earnings, balancing the fund's attractive high yields and new weekly distributions against ongoing concerns about NAV erosion and its capped upside compared to the underlying stock.

Halliburton Co. engages in the provision of products and services to the energy industry. It operates through the Completion and Production, and Drilling and Evaluation segments. The Completion and Production segment focuses on cementing, stimulation, specialty chemicals, intervention, pressure control, artificial lift, and completion products and services. The Drilling and Evaluation segment provides field and reservoir modeling, drilling, fluids, evaluation, and wellbore placement solutions that enable customers to model, measure, drill, and optimize well construction activities. The company was founded by Erle P. Halliburton in 1919 and is headquartered in Houston, TX.

Halliburton Co.

Halliburton is at the forefront of investor conversations after delivering a strong Q4 earnings beat and signaling a potential strategic re-entry into Venezuela's lucrative oil market, further boosted by a new venture into powering data centers. The community sees significant upside as the energy sector benefits from rising crude prices amid global geopolitical shifts.

statis crypto Watchlist

Bitcoin

Ethereum

Solana

Ripple

Dogecoin

Cardano

statis IN Watchlist

Nifty 50

Nifty Bank

Reliance Industries Ltd.

Zomato Ltd.

Tata Consultancy Services

Tata Motors Ltd.

HDFC Bank Ltd.

ITC Ltd.

Adani Enterprises Ltd

Axis Bank Ltd

Bajaj Finance Ltd

statis US Watchlist

SPDR S&P 500 ETF

Apple Inc.

Tesla Inc

Microsoft Corporation

NVIDIA Corp

 Hey, I want to invite you to join Stocktwits. It’s the largest global community of active traders. You’ll get access to the real-time market insights, news, discussion and much more! You can sign up using my unique link below 
 


 has invited you to join Stocktwits

Biotech stocks are a hot-button topic for retail investors on Stocktwits, where over&nbsp;four million users track these companies, hoping to spot the next big therapeutic breakthrough.Two names currently trending in the space are Mainz Biomed, a molecular genetics cancer diagnostic company based in Germany, and Aurinia Pharmaceuticals Inc., a Canadian biopharmaceutical firm focused on autoimmune disease treatments.Over the past three months, Mainz has seen a staggering 2,500% increase in message volume on Stocktwits, while Aurinia’s engagement has grown just 23%.&nbsp;However, Aurinia maintains nearly three times the following of Mainz on the platform.&nbsp;A recent Stocktwits poll of over 1,100 respondents found that 53% believe Mainz offers more upside, compared to 34% favoring Aurinia.<figure class="image"><img style="aspect-ratio:1294/736;" src="https://st-everywhere-cms-prod.s3.us-east-1.amazonaws.com/MYNZ_vs_AUPH_poll_as_of_March_6_43ea585c2e.png" alt="MYNZ vs AUPH poll as of March 6.png" width="1294" height="736"><figcaption>MYNZ vs AUPH poll as of March 6. | source: Stocktwits</figcaption></figure>Maxim Group recently initiated coverage on Mainz with a ‘Buy’ rating and a $14 price target, highlighting its role in the $4 billion colorectal cancer screening market.&nbsp;The firm is optimistic about Mainz’s next-generation test, which uses mRNA biomarkers to improve the detection of pre-cancerous adenomas and potentially enhance colorectal cancer prevention.&nbsp;Mainz is conducting a clinical study on this test, with data expected in the second half of 2025, and plans to finalize protocols for a pivotal U.S. study in 2026.In October, Mainz reported fiscal first-half loss per share had narrowed to $0.48 from $1 a year earlier, with revenue rising to $520,773 from $499,049.&nbsp;The company’s cash and cash equivalents stood at $977,764.Retail traders on Stocktwits have pointed to increasing institutional investment in Mainz, with funds such as Artisan Mid Cap Fund reportedly raising their stakes.&nbsp;<stembedurl>https://stocktwits.com/CarterWood/message/607119518</stembedurl>Some traders speculate that Mainz could see significant catalysts, including an upcoming product launch, a potential partnership, accelerated clinical progress, or an FDA resubmission with fast-track approval.<stembedurl>https://stocktwits.com/FosterD_Nightfall/message/607091090</stembedurl>Aurinia, in contrast, has gained attention for its development of AUR200, a therapy targeting BAFF (B-cell Activating Factor) and APRIL (A Proliferation-Inducing Ligand). The company believes this could become a best-in-class treatment for autoimmune diseases.&nbsp;It has already commercialized Lupkynis, the first FDA-approved oral therapy for adult patients with active lupus nephritis.In its latest financial report, Aurinia posted fourth-quarter earnings of $0.01 per diluted share, a sharp turnaround from a $0.19 loss a year earlier and better than analysts’ projected $0.02 per-share loss.&nbsp;Revenue for the quarter rose to $59.9 million from $45.1 million a year earlier but fell slightly below Wall Street estimates of $60.1 million.&nbsp;For 2025, Aurinia forecasts revenue between $250 million and $260 million, trailing the $274.4 million expected by analysts.Last year, Aurinia said it would <a href="https://stocktwits.com/news-articles/markets/equity/auph-stock-surges-on-insider-buying/cJa2dg8Rin">strengthen</a> its financial position by cutting nearly half its staff to save over $40 million annually.&nbsp;The company also made leadership changes, including CEO Peter Greenleaf’s conditional resignation as a director.&nbsp;As of Dec. 31, 2024, Aurinia held cash, cash equivalents, and investments totaling $358.5 million, up slightly from $350.7 million a year earlier.According to Koyfin data, short interest in Aurinia stood at 7%, compared to 5.1% for Mainz.&nbsp;Over the past year, Aurinia shares have gained more than 44%, though they are down over 9% year-to-date.&nbsp;Mainz, meanwhile, has fallen more than 86% in the past 12 months but has rebounded over 25% since the start of this year.For updates and corrections, email newsroom[at]stocktwits[dot]com.

Mainz Biomed Vs. Aurinia Pharma: Retail Traders Weigh In On The Better Biotech Bet

Over the past three months, Mainz has seen a staggering 2,500% increase in message volume on Stocktwits, while Aurinia’s engagement has grown just 23%. 

Equity

Mainz Biomed NV is a molecular genetics cancer diagnostic company. The firm is engaged in the developing of market-ready molecular genetic diagnostic solutions for life-threatening conditions. It is involved in the commercializing of its product portfolio in Europe, the United States, and the rest of world. The company was founded on March 08, 2021 and is headquartered in Mainz, Germany.

MYNZ
Mainz Biomed B.V.

Feed

News

Sentiment

Fundamentals

Info

Poll

Latest MYNZ News

MYNZMainz Biomed B.V.